Alpha Fusion, Curadh MTR Partner on Astatine-211 Drugs

Alpha Fusion and Curadh MTR partner to co-develop Astatine-211-based targeted alpha therapies, aiming to improve cancer treatment with next-gen radiopharmaceuti...

• Prisha